Similar activation state of neutrophils in sputum of asthma patients irrespective of sputum eosinophilia

Clinical and Experimental Immunology

Volumn 182, Issue 2, 2015, Pages 204-212

  Tak, T ^a   Hilvering, B ^a   Tesselaar, K ^a   Koenderman, L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cell surface molecules; Lung; Neutrophils

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CD11B ANTIGEN; CD69 ANTIGEN; CELL SURFACE MARKER; CORTICOSTEROID; L SELECTIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING BETA AGONIST; PROGRAMMED DEATH 1 LIGAND 1; SALBUTAMOL; SHORT ACTING BETA AGONIST; UNCLASSIFIED DRUG; LECTIN; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEGRANULATION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CONTROL; DRUG MEGADOSE; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LOW DRUG DOSE; MALE; MIDDLE AGED; NEUTROPHIL; NEUTROPHIL COUNT; NONPARAMETRIC TEST; PHENOTYPE; PREDICTIVE VALUE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; SCORING SYSTEM; SPUTUM; SPUTUM ANALYSIS; BLOOD; CELL SURVIVAL; COMPLICATION; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD11B; ANTIGENS, CD274; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ASTHMA; CELL SURVIVAL; EOSINOPHILIA; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HUMANS; L-SELECTIN; LECTINS, C-TYPE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; PRINCIPAL COMPONENT ANALYSIS; SPUTUM;

EID: 84944167464     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12676     Document Type: Article

References (43)

1. Global Initiative for Asthma (GINA). Gina report, global strategy for asthma management and prevention. Available at: http://www.ginasthma.org/. 2012. Accessed February 2 2014.
2. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11:54-61.
3. Woodruff PG, Khashayar R, Lazarus SC et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001; 108:753-8.
4. Wagener AH, de Nijs SB, Lutter R et al. External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma. Thorax 2015; 70:115-20.
5. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52:498-501.
6. Baines KJ, Simpson JL, Wood LG et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol 2014; 133:997-1007.
7. Brooks CR, van Dalen CJ, Hermans IF, Douwes J. Identifying leukocyte populations in fresh and cryopreserved sputum using flow cytometry. Cytometry B Clin Cytom 2013; 84:104-13.
8. Dominguez OJ, Leon F, Martinez Alonso JC et al. Fluorocytometric analysis of induced sputum cells in an asthmatic population. J Investig Allergol Clin Immunol 2004; 14:108-13.
9. Lay JC, Peden DB, Alexis NE. Flow cytometry of sputum: assessing inflammation and immune response elements in the bronchial airways. Inhal Toxicol 2011; 23:392-406.
10. Vidal S, Bellido-Casado J, Granel C, Crespo A, Plaza V, Juarez C. Flow cytometry analysis of leukocytes in induced sputum from asthmatic patients. Immunobiology 2012; 217:692-7.
11. Alexis N, Soukup J, Ghio A, Becker S. Sputum phagocytes from healthy individuals are functional and activated: a flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood. Clin Immunol 2000; 97:21-32.
12. Hansel TT, Braunstein JB, Walker C et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 1991; 86:271-7.
13. in't Veen JC, Grootendorst DC, Bel EH et al. CD11b and L-selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects. Clin Exp Allergy 1998; 28:606-15.
14. Baines KJ, Simpson JL, Wood LG, Scott RJ, Gibson PG. Systemic upregulation of neutrophil alpha-defensins and serine proteases in neutrophilic asthma. Thorax 2011; 66:942-7.
15. Johansson MW. Activation states of blood eosinophils in asthma. Clin Exp Allergy 2014; 44:482-98.
16. Gundel RH, Wegner CD, Torcellini CA et al. Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and late-phase airway obstruction in monkeys. J Clin Invest 1991; 88:1407-11.
17. Risso A, Cosulich ME, Rubartelli A, Mazza MR, Bargellesi A. MLR3 molecule is an activation antigen shared by human B, T lymphocytes and T cell precursors. Eur J Immunol 1989; 19:323-8.
18. Gullberg U, Bengtsson N, Bulow E, Garwicz D, Lindmark A, Olsson I. Processing and targeting of granule proteins in human neutrophils. J Immunol Methods 1999; 232:201-10.
19. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89:3503-21.
20. Adkinson NF, Bochner BS, Burks W, Busse WW, Holgate ST. Middleton's allergy: principles and practice. Philadelphia, PA: Elsevier-Health Sciences Division, 2013.
21. Mallia P, Message SD, Contoli M et al. Neutrophil adhesion molecules in experimental rhinovirus infection in COPD. Respir Res 2013; 14:72.
22. Tirouvanziam R, Gernez Y, Conrad CK et al. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 2008; 105:4335-9.
23. Berends C, Hoekstra MO, Dijkhuizen B, de Monchy JG, Gerritsen J, Kauffman HF. Expression of CD35 (CR1) and CD11b (CR3) on circulating neutrophils and eosinophils from allergic asthmatic children. Clin Exp Allergy 1993; 23:926-33.
24. Lundahl J, Skedinger M, Hed J, Johansson SG, Zetterstrom O. Lability in complement receptor mobilization of granulocytes in patients with bronchial hyperreactivity. Clin Exp Allergy 1992; 22:834-8.
25. Akbari O, Stock P, Singh AK et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol 2010; 3:81-91.
26. de Kleijn S, Langereis JD, Leentjens J et al. Stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1. PLOS ONE 2013; 8:e72249.
27. Braun NA, Celada LJ, Herazo-Maya JD et al. Blockade of the programmed death-1 pathway restores sarcoidosis CD4+ T cells proliferative capacity. Am J Respir Crit Care Med 2014; 190:560-71.
28. Linting M, van der Kooij A. Nonlinear principal components analysis with CATPCA: a tutorial. J Pers Assess 2012; 94:12-25.
29. Wu W, Bleecker E, Moore W et al. Unsupervised phenotyping of Severe Asthma Research Program participants using expanded lung data. J Allergy Clin Immunol 2014; 133:1280-8.
30. Haldar P, Pavord ID, Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-24.
31. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39:175-91.
32. Sennels HP, Jorgensen HL, Goetze JP, Fahrenkrug J. Rhythmic 24-hour variations of frequently used clinical biochemical parameters in healthy young males - the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 2012; 72:287-95.
33. Mattes J, Storm van's Gravesande K, Moeller C, Moseler M, Brandis M, Kuehr J. Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children. Pediatr Res 2002; 51:190-4.
34. Rutgers SR, Timens W, Kaufmann HF, van der Mark TW, Koeter GH, Postma DS. Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J 2000; 15:109-15.
35. Efthimiadis A, Spanevello A, Hamid Q et al. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl 2002; 37:19s-23s.
36. Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010; 79:147-51.
37. Mahmudi-Azer S, Downey GP, Moqbel R. Translocation of the tetraspanin CD63 in association with human eosinophil mediator release. Blood 2002; 99:4039-47.
38. van Velzen JF, Laros-van Gorkom BA, Pop GA, van Heerde WL. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers. Thromb Res 2012; 130:92-8.
39. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995; 184:39-51.
40. Fortunati E, Kazemier KM, Grutters JC, Koenderman L, Van den Bosch vJ. Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol 2009; 155:559-66.
41. Danielsson C, Pascual M, French L, Steiger G, Schifferli JA. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 1994; 24:2725-31.
42. Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel PL. Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 1993; 150:4061-71.
43. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW. The effect of transendothelial migration on eosinophil function. Am J Respir Cell Mol Biol 2000; 23:379-88.